AlphaFold predicted structure
SOCS1 · O15524

Mean pLDDT
83.1/ 100
Confident
211 residues
Confidence breakdown
- Very high(≥ 90)66%
- Confident(70–90)9%
- Low(50–70)15%
- Very low(< 50)10%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
suppressor of cytokine signaling 1
Annotations refreshed 9 hours ago.
Diagnostic Grade (Green)
Primary immunodeficiency or monogenic inflammatory bowel disease
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedCOVID-19 research
Unknownautoinflammatory syndrome with immunodeficiency
diffuse large B-cell lymphoma
psoriasis
common variable immunodeficiency
lymphoma
psoriasis vulgaris
Hodgkins lymphoma
lymphoid neoplasm
non-functioning pituitary adenoma
neoplasm of mature B-cells
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Suppressor of cytokine signaling 1
Essential negative regulator of type I and type II interferon (IFN) signaling, as well as that of other cytokines, including IL2, IL4, IL6 and leukemia inhibitory factor (LIF) (PubMed:32499645, PubMed:33087723). Downregulates cytokine signaling by inhibiting the JAK/STAT signaling pathway. Acts by binding to JAK proteins and to IFNGR1 and inhibiting their kinase activity. In vitro, suppresses Tec protein-tyrosine activity (PubMed:9341160). Regulates IFN-gamma (IFNG)-mediated sensory neuron survival (By similarity). Probable substrate recognition component of an ECS (Elongin BC-CUL2/5-SOCS-box protein) E3 ubiquitin ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins (PubMed:11278610, PubMed:11313480)
SOCS1 · O15524

Mean pLDDT
83.1/ 100
Confident
211 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0